B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

2022406 citationsJournal Articlehybrid Open Access

Authors

NCT02550652.

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 81, Issue 1, pp. 100-107

Field-Weighted Citation Impact: 64.35